The latest American Heartworm Society survey shows Texas now leads the nation in canine heartworm incidence, while new hotspots and expanding case clusters are emerging in regions previously considered lower risk.
The Companion Animal Parasite Council’s 2026 forecast projects continued expansion of Lyme disease, heartworm, ehrlichiosis, and anaplasmosis, reinforcing the need for year-round prevention and surveillance.
The FDA has approved an expanded label for BRAVECTO QUANTUM, adding 12-month protection against Asian longhorned and Gulf Coast ticks in dogs.
Veterinarians across the U.S. are seeing early parasite activity as temperatures rise, reinforcing the need for year-round prevention in pets.
The FDA has approved expanded labels for Elanco’s Credelio™ and Credelio Quattro™, adding prevention of Lyme disease and protection against the rapidly spreading longhorned tick—now found in 22 U.S. states.
The FDA has granted an Emergency Use Authorization for Elanco’s Credelio™ (lotilaner) to treat New World screwworm infestations in dogs—marking the first authorization of its kind as the parasite nears the U.S. border.
Sign up for free to receive the latest veterinary news, product announcements, and industry developments.